The Online Investor
OLI Premium
Retiree Portfolio
Stock Option Ideas
Preferred Stock List
ChartZero.com
ChartZero

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Thu., Nov. 27, 7:06 PM

Slide #1. Medgenics, Inc. Secondary Offering

Company: Medgenics, Inc. (AMEX:MDGN)
Date announced: 11/24/2014
Shares Offered: 5,125,000
Date of Pricing: 11/25/2014
Price Per Share: $4.10
Secondary Offering Details: Medgenics, Inc. (NYSE MKT:MDGN) today announced that it intends to offer and sell shares of its common stock in an underwritten public offering. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. As part of this proposed offering, Medgenics intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of common stock offered to the public. Medgenics has developed a proprietary ex vivo gene therapy platform for the sustained production and delivery of therapeutic proteins and peptides using a patient's own tissue. The company focuses on rare and orphan diseases. - updated 11/25 - Medgenics, Inc. (NYSE MKT:MDGN) today announced the pricing of 5,125,000 shares of its common stock in a previously announced underwritten public offering at a price to the public of $4.10 per share. In connection with the offering, Medgenics has also granted the underwriters a 30-day option to purchase up to an additional 768,750 shares of its common stock. Gross proceeds to Medgenics from the sale of shares are expected to be approximately $21.0 million, excluding any exercise of the underwriters' option to purchase additional shares of common stock. If the underwriters' option is exercised in full, gross proceeds will be $24.2 million. The offering is expected to close on or about December 1, 2014 subject to customary closing conditions.

Medgenics is a medical technology and therapeutics company developing a platform technology for orphan and rare diseases therapeutics market. Co.'s Biopump Platform Technology is designed to provide sustained protein/peptide therapy to treat a range of chronic diseases and conditions. Co. develops a device called the DermaVac to facilitate removal of micro-organs and implantation of Biopumps. Co. produces Biopumps which have demonstrated the capability for sustained production of therapeutic proteins, including erythropoietin to treat anemia (EPODURE), interferon-alpha (INF-a) to treat various forms of hepatitis (INFRADURE) and Factor VIII clotting protein to treat hemophilia (HEMODURE).
Open the MDGN Page at The Online Investor »

Company Name:  Medgenics Inc
Website:  www.medgenics.com
Sector:  Biotechnology
Number of ETFs Holding MDGN:  2
Total Market Value Held by ETFs:  $245436
Total Market Capitalization:  $81.00M
% of Market Cap. Held by ETFs:  0.30%
 

Open the MDGN Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

11/17/2014:
Company: CorEnergy Infrastructure Trust, Inc. (CORR)
Shares Offered: 13,000,000
More: offering details »

11/17/2014:
Company: Receptos (RCPT)
Shares Offered: 3,600,000
More: offering details »

11/17/2014:
Company: Rockwell Medical, Inc. (RMTI)
Shares Offered: 6,500,000
More: offering details »

11/17/2014:
Company: Moelis & Company (MC)
Shares Offered: 5,500,000
More: offering details »

11/17/2014:
Company: Amicus Therapeutics (FOLD)
Shares Offered: 13,850,000
More: offering details »

11/17/2014:
Company: Essent Group Ltd. (ESNT)
Shares Offered: 6,000,000
More: offering details »

11/17/2014:
Company: Signature Group Holdings, Inc. (SGGH)
Shares Offered: 3,700,000
More: offering details »

11/17/2014:
Company: La Quinta Holdings Inc. (LQ)
Shares Offered: 20,000,000
More: offering details »

11/17/2014:
Company: Continental Building Products, Inc. (CBPX)
Shares Offered: 7,000,000
More: offering details »

11/18/2014:
Company: Pinnacle Foods Inc. (PF)
Shares Offered: 20,000,000
More: offering details »

11/18/2014:
Company: Cloud Peak Energy Inc. (CLD)
Shares Offered: 100,000
More: offering details »

11/19/2014:
Company: Lexicon Pharmaceuticals, Inc. (LXRX)
Shares Offered: 49,751,244
More: offering details »

11/19/2014:
Company: Independence Realty Trust, Inc. (IRT)
Shares Offered: 6,000,000
More: offering details »

11/19/2014:
Company: Walker & Dunlop, Inc. (WD)
Shares Offered: 2,000,000
More: offering details »

11/20/2014:
Company: Oxford Lane Capital Corp. (OXLC)
Shares Offered: 1,000,000
More: offering details »

11/20/2014:
Company: Autohome Inc. (ATHM)
Shares Offered: 6,850,000
More: offering details »

11/20/2014:
Company: GoPro, Inc. (GPRO)
Shares Offered: 10,360,500
More: offering details »

11/21/2014:
Company: TCP Capital Corp. (TCPC)
Shares Offered: 5,900,000
More: offering details »

11/21/2014:
Company: On Track Innovations Ltd (oti) (OTIV)
Shares Offered: 6,250,000
More: offering details »

11/21/2014:
Company: Public Storage (PSA)
Shares Offered: 7,000,000
More: offering details »

11/21/2014:
Company: Perrigo Company plc (PRGO)
Shares Offered: 5,921,053
More: offering details »

11/21/2014:
Company: New York Mortgage Trust, Inc. (NYMT)
Shares Offered: 13,000,000
More: offering details »

11/21/2014:
Company: Endurance International Group Holdings, Inc. (EIGI)
Shares Offered: 13,000,000
More: offering details »

11/24/2014:
Company: Revolution Lighting Technologies, Inc. (RVLT)
Shares Offered: 8,000,000
More: offering details »

11/24/2014:
Company: Medgenics, Inc. (MDGN)
Shares Offered: 5,125,000
More: offering details »

November 27, 2014    7:06 PM Eastern
Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings | www.TheOnlineInvestor.com | Copyright © 1998 - 2014, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.